L

Lembas at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Lembas brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program centres on GLP-1 Edge, an oral GPR40 agonist that acts locally in the gut to support weight management. One study reports better blood sugar control after meals in adults with prediabetes and obesity.

OrganizationObesityWeek 2026 Attendance
L
Lembas
Nutrition products
Israeli startup developing a food-grade bioactive peptide, for use in foods and supplements, that boosts the body's own GLP-1 response.
Poster
Sat Nov 14
7:30pm–8:30pm
GLP-1 Edge™ Improves Postprandial Glycemic Control in Adults With Prediabetes and Obesity
Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology
Poster
Sat Nov 14
7:30pm–8:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Lembas

Tell us what you sell and we’ll find the people at Lembas most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction